Literature DB >> 22346256

Potential implications of Helicobacter pylori-related neutrophil-activating protein.

Jannis Kountouras, Christos Zavos, Georgia Deretzi, Emmanuel Gavalas, Dimitrios Chatzopoulos, Panagiotis Katsinelos, Elena Tsiaousi, Stergios Gagalis, Stergios A Polyzos, Ioannis Venizelos.   

Abstract

Helicobacter pylori (H. pylori) virulence factors promote the release of various chemoattractants/inflammatory mediators, including mainly the neutrophil-attractant chemokine interleukin-8 and neutrophil-activating protein (NAP), involved in H. pylori-induced gastric pathologies. Co-administration of Chios mastic gum (CMG), which inhibits H. pylori NAP, with an H. pylori eradication regimen might add clinical benefits against H. pylori-related gastric pathologies, but possibly not CMG as main therapy. Although H. pylori NAP and other H. pylori-related cytotoxins [i.e., vaculating cytotoxin (VacA)] appear to play a major role in generating and maintaining the H. pylori-associated gastric inflammatory response and H. pylori NAP is a promising vaccine candidate against H. pylori infection (H. pylori-I), concerns regarding its potential drawbacks, particularly neurogenic ones, due to possible cross-mimicry, should be considered. Possible cross-mimicry between H. pylori NAP and/or bacterial aquaporin (AQP) and neural tissues may be associated with the anti-AQP-4 antibody-related neural damage in multiple sclerosis (MS)/neuromyelitis optica patients. Moreover, the sequence homology found between H. pylori VacA and human Na+/K+-ATPase A subunit suggests that antibodies to VacA involve ion channels in abaxonal Schwann cell plasmalemma resulting in demyelination in some patients. A series of factors have been implicated in inducing blood-brain barrier (BBB) disruption, including inflammatory mediators (e.g., cytokines and chemokines induced by H. pylori-I) and oxidative stress. BBB disruption permits access of AQP4-specific antibodies and T lymphocytes to the central nervous system, thereby playing a major role in multiple sclerosis pathogenesis. Relative studies show a strong association between H. pylori-I and MS. H. pylori-I induces humoral and cellular immune responses that, owing to the sharing of homologous epitopes (molecular mimicry), cross-react with components of nerves, thereby contributing and perpetuating neural tissue damage. Finally, H. pylori NAP also plays a possible pathogenetic role in both gastric and colon oncogenesis.

Entities:  

Keywords:  Chios mastic gum; Cross-mimicry; Demyelination; Gastric carcinogenesis; Helicobacter pylori; Multiple sclerosis; Neutrophil-activating protein

Mesh:

Substances:

Year:  2012        PMID: 22346256      PMCID: PMC3270508          DOI: 10.3748/wjg.v18.i5.489

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  6 in total

1.  Helicobacter pylori and multiple sclerosis.

Authors:  Emmanuel Gavalas; Jannis Kountouras; Georgia Deretzi; Marina Boziki; Nikolaos Grigoriadis; Christos Zavos; Ioannis Venizelos
Journal:  J Neuroimmunol       Date:  2007-07-05       Impact factor: 3.478

2.  Guillain-Barré syndrome.

Authors:  Jannis Kountouras; Georgia Deretzi; Nikolaos Grigoriadis; Christos Zavos; Marina Boziki; Emmanuel Gavalas; Panagiotis Katsinelos; Dimitrios Tzilves; Olga Giouleme; Georgia Lazaraki
Journal:  Lancet Neurol       Date:  2008-12       Impact factor: 44.182

3.  Helicobacter pylori with or without its neutrophil-activating protein may be the common denominator associated with multiple sclerosis and neuromyelitis optica.

Authors:  Jannis Kountouras; Emmanuel Gavalas; Georgia Deretzi; Marina Boziki; Christos Zavos; Dimitrios Chatzopoulos; Panagiotis Katsinelos; Evangelia Giartza-Taxidou; Nikolaos Grigoriadis; Ioannis Venizelos
Journal:  Mult Scler       Date:  2010-03       Impact factor: 6.312

4.  Helicobacter pylori neutrophil activating protein as target for new drugs against H. pylori inflammation.

Authors:  Theodora Choli-Papadopoulou; Filippos Kottakis; Georgios Papadopoulos; Stefanos Pendas
Journal:  World J Gastroenterol       Date:  2011-06-07       Impact factor: 5.742

Review 5.  Reactive oxygen metabolites and upper gastrointestinal diseases.

Authors:  J Kountouras; D Chatzopoulos; C Zavos
Journal:  Hepatogastroenterology       Date:  2001 May-Jun

6.  Effects of mastic gum Pistacia lentiscus var. Chia on innate cellular immune effectors.

Authors:  Filippos Kottakis; Kokona Kouzi-Koliakou; Stefanos Pendas; Jannis Kountouras; Theodora Choli-Papadopoulou
Journal:  Eur J Gastroenterol Hepatol       Date:  2009-02       Impact factor: 2.566

  6 in total
  4 in total

1.  The Role of Chronic Infection in Alzheimer's Disease: Instigators, Co-conspirators, or Bystanders?

Authors:  Lauren Butler; Keenan A Walker
Journal:  Curr Clin Microbiol Rep       Date:  2021-04-24

Review 2.  Brain-gut axis in the pathogenesis of Helicobacter pylori infection.

Authors:  Jacek Budzyński; Maria Kłopocka
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

3.  Serum Helicobacter pylori NapA antibody as a potential biomarker for gastric cancer.

Authors:  Jingjing Liu; Huimin Liu; Tingting Zhang; Xiyun Ren; Christina Nadolny; Xiaoqun Dong; Lina Huang; Kexin Yuan; Wenjing Tian; Yunhe Jia
Journal:  Sci Rep       Date:  2014-02-20       Impact factor: 4.379

4.  Production and delivery of Helicobacter pylori NapA in Lactococcus lactis and its protective efficacy and immune modulatory activity.

Authors:  Xiaoyan Peng; Rongguang Zhang; Guangcai Duan; Chen Wang; Nan Sun; Linghan Zhang; Shuaiyin Chen; Qingtang Fan; Yuanlin Xi
Journal:  Sci Rep       Date:  2018-04-24       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.